Lumipulse® G SARS-CoV-2 N-IgG Controls

For in vitro diagnostic (IVD) use as quality controls, to monitor the precision and accuracy of the Lumipulse G SARS-CoV-2 N-IgG assay on the automated LUMIPULSE G System. The assay using this control is performed to quantitatively measure IgG antibodies to SARS-CoV-2 nucleocapsid (N) protein in human serum or plasma and is intended to be used in the assessment of the immune response to the SARS-CoV-2 N protein.

CE marked
Lumipulse® G SARS-CoV-2 N-IgG Controls

Product number 232354

2 x 2 Concentrations
Contact sales for information and inquiries

Click here to navigate

  • Conditions of sale
  • Documentation
  • Insights
  • Related products
  • Product inquiry